EP Device Marker Settles Government Suit for $22 Million

December 24, 2009 – The U.S. Department of Justice and Boston Scientific Corp. yesterday entered into a civil settlement regarding an investigation of post-market surveys conducted by Guidant Corp., before Boston Scientific acquired the company in 2006.

The investigation began in 2005 and was conducted by the U.S. attorney’s office in Boston. Under the terms of the settlement the company does not admit to any wrong doing, but will pay $22 million. The company also agreed to enter into a corporate integrity agreement (CIA) with the Office of Inspector General for the U.S. Department of Health and Human Services. The CIA requires enhancements to certain compliance procedures related to financial arrangements with healthcare providers. It is limited to the company’s cardiac rhythm management business, which became part of Boston Scientific through the Guidant acquisition.

For more information, please visit: www.bostonscientific.com.